Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508068 | SCV001713974 | uncertain significance | not provided | 2020-12-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821802 | SCV002067257 | uncertain significance | not specified | 2019-02-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001882550 | SCV002274559 | uncertain significance | Dyskeratosis congenita | 2024-12-04 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 451 of the DKC1 protein (p.Ser451Arg). This variant is present in population databases (rs370788135, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with DKC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1163206). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DKC1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005040299 | SCV005683139 | uncertain significance | Dyskeratosis congenita, X-linked; Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1 | 2024-05-15 | criteria provided, single submitter | clinical testing |